Cantel Medical reports 15% increase in sales in Q4: 6 key notes

Cantel Medical reports 15% increase in sales in Q4: 6 key notes
Cantel Medical has reported its financial results for the fourth quarter of ended July 31, 2015.

Advertisement

Here are six key notes:

1. The company reported record US GAAP net income of $13.2 million in the fourth quarter of this year,  a 15 percent increase in sales to a record $151.2 million. In the fourth quarter of 2014, the company reported US GAAP income of $10.7 million

2. For the full fiscal year ended July 31, 2015, the company reported record US GAAP net income of $47.9 million on a 16 percent increase in sales to a record $565 million, as compared to a net income of $43.2 last year.

3. Under non-GAAP measures, adjusted net income increased 19 percent this quarter to $16.06 million.

4. For the full fiscal year ended July 31, 2015, the company reported a 17 percent increase in adjusted net income to $60.03.

5. According to Andrew Krakauer, CEO of Cantel Medical, “[The] Medivators Endoscopy segment led sales growth for the company this quarter with a robust year-over-year increase of 27 percent, of which 17 percent was organic.”

6. For the full fiscal year 2015, adjusted EBITDAS grew by 17 percent to nearly $114 million, noted Mr. Krakauer.

More articles on GI/endoscopy:
FDA approves new CRC drug
Beyond patient care: The biggest challenges in GI
4 GI physicians in the news – Sept. 25, 2015

At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.

Advertisement

Next Up in GI & Endoscopy

Advertisement

Comments are closed.